Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Histone Variants at the Centromere02:30

Histone Variants at the Centromere

5.1K
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
5.1K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

302
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
302
Autophagic Cell Death01:18

Autophagic Cell Death

4.5K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.5K
Overview of Cell Death01:30

Overview of Cell Death

10.1K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
10.1K
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

652
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
652
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

1.0K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Natural History of Asymptomatic Phenotypically Mild HCM: Insights From the SHaRe Registry.

Journal of the American College of Cardiology·2026
Same author

Utility of genetic testing in athletes with suspected inherited cardiac conditions.

European journal of preventive cardiology·2026
Same author

Correction to: The Natural History of Massive Left Ventricular Hypertrophy in Pediatric Hypertrophic Cardiomyopathy: A Multiregistry Analysis.

Circulation·2026
Same author

Cardiomyopathy and Sudden Cardiac Death as a Rare Presentation of Mucolipidosis Type III in a Family With Compound Heterozygous Variants in <i>GNPTAB</i>.

Circulation. Genomic and precision medicine·2026
Same author

Ventricular conduction is a marker for arrhythmic risk in SCN5A-E1784K overlap sodium channel disease.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026
Same author

The Natural History of Massive Left Ventricular Hypertrophy in Pediatric Hypertrophic Cardiomyopathy: A Multiregistry Analysis.

Circulation·2026

Related Experiment Video

Updated: Feb 4, 2026

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER
14:06

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER

Published on: June 23, 2012

15.7K

Exome-Wide Rare Variant Analyses in Sudden Infant Death Syndrome.

David J Tester1, Leonie C H Wong2, Pritha Chanana3

  • 1Department of Cardiovascular Medicine (Division of Heart Rhythm Services), Pediatrics (Division of Pediatric Cardiology), Molecular Pharmacology & Experimental Therapeutics (Windland Smith Rice Sudden Death Genomics Laboratory), Mayo Clinic, Rochester, MN.

The Journal of Pediatrics
|October 1, 2018
PubMed
Summary
This summary is machine-generated.

Whole-exome sequencing in sudden infant death syndrome (SIDS) cases found no single gene cause. This suggests SIDS has diverse genetic origins, highlighting the need for broad research into its complex biological pathways.

Keywords:
inherited cardiac conditionsmolecular autopsysudden infant death syndromewhole exome sequencing

More Related Videos

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

14.4K
Detection of a CDH1 Rare Transcript Variant in Fresh-frozen Gastric Cancer Tissues by Chip-based Digital PCR
09:16

Detection of a CDH1 Rare Transcript Variant in Fresh-frozen Gastric Cancer Tissues by Chip-based Digital PCR

Published on: February 5, 2018

6.6K

Related Experiment Videos

Last Updated: Feb 4, 2026

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER
14:06

Detection of Rare Genomic Variants from Pooled Sequencing Using SPLINTER

Published on: June 23, 2012

15.7K
In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

14.4K
Detection of a CDH1 Rare Transcript Variant in Fresh-frozen Gastric Cancer Tissues by Chip-based Digital PCR
09:16

Detection of a CDH1 Rare Transcript Variant in Fresh-frozen Gastric Cancer Tissues by Chip-based Digital PCR

Published on: February 5, 2018

6.6K

Area of Science:

  • Genetics
  • Pediatrics
  • Pathology

Background:

  • Sudden Infant Death Syndrome (SIDS) remains a significant concern in infant mortality.
  • The underlying causes of SIDS are not fully understood, with genetic factors suspected but not definitively identified.
  • Previous research has explored genetic contributions, but a comprehensive exome-wide analysis was needed.

Purpose of the Study:

  • To investigate a potential monogenic (single-gene) basis for Sudden Infant Death Syndrome (SIDS).
  • To utilize whole-exome sequencing to identify rare genetic variants associated with SIDS.
  • To explore novel candidate genes and biological pathways implicated in SIDS etiology.

Main Methods:

  • Whole-exome sequencing was performed on a cohort of 427 unrelated SIDS cases.
  • Exome-wide rare variant analyses were conducted comparing SIDS cases (n=278) of European ancestry to ethnic-matched controls (n=973) using six genetic models.
  • Ingenuity Pathway Analysis was employed to identify biological pathways associated with identified variants.

Main Results:

  • No exome-wide significant association (P < 2.5 × 10⁻⁶) was found for the burden of ultra-rare variants in any gene.
  • However, 405 genes showed a higher prevalence (P < .05) of ultra-rare nonsynonymous variants in SIDS cases, with 17 genes at P < .005.
  • Glucocorticoid biosynthesis was identified as the top canonical pathway (P = .01), suggesting a potential biological link.

Conclusions:

  • The absence of exome-wide significant genetic associations indicates extreme heterogeneity in the causes of SIDS.
  • The findings suggest that SIDS likely results from a complex interplay of genetic and environmental factors rather than a single gene.
  • Perturbations in glucocorticoid biosynthesis may represent a novel pathway for future SIDS research.